APOA5 and melanoma: To explore whether the identified proteins, APOA5, PON1, PON3, CD14 and RAP1B, could be of any clinical relevance, we evaluated their expression in silico in relation to the available clinical information in the TCGA dataset of primary melanoma samples (PM, n = 80).